Valuation : Dermapharm Holding SE

Market Cap 1.93B 2.24B 1.81B 1.66B 3.09B 212B 3.12B 21.42B 8.34B 108B 8.42B 8.24B 349B P/E 2026 *
14.9x
P/E 2027 * 13.1x
Enterprise Value 2.74B 3.19B 2.57B 2.35B 4.39B 301B 4.43B 30.43B 11.85B 154B 11.96B 11.7B 496B EV / Sales 2026 *
2.27x
EV / Sales 2027 * 2.09x
Free-Float
10.7%
Yield 2026 *
2.62%
Yield 2027 * 2.92%
1 day+1.70%
1 week-2.87%
Current month-0.13%
1 month-5.00%
3 months-20.02%
6 months+2.50%
Current year-1.02%
1 week 38.3
Extreme 38.3
40.15
1 month 38.3
Extreme 38.3
42.25
Current year 34.3
Extreme 34.3
51.9
1 year 31.7
Extreme 31.7
51.9
3 years 30.15
Extreme 30.15
51.9
5 years 30.15
Extreme 30.15
91.95
10 years 21.58
Extreme 21.575
91.95
Manager TitleAgeSince
Chief Executive Officer 64 01/08/2017
Director of Finance/CFO - 01/11/2022
Investor Relations Contact - 01/12/2018
Director TitleAgeSince
Chairman 70 01/08/2017
Director/Board Member 66 01/08/2017
Director/Board Member 77 01/01/2018
Date Insider Type Main position Quantity % Market Cap. Importance
5/14/26 A Buy

Chairman

380,000 0.7670%
1/7/26 A Buy 150 0.0003%
1/7/26 A Buy 150 0.0003%
Change 5-day change 1-year change 3-year change Capi.($)
+1.70%-2.87%+18.03%-13.64% 2.2B
-0.04%-1.40%+57.16%+108.15% 1,034B
+1.17%+4.76%+56.42%+73.50% 663B
-0.58%+0.80%+22.82%+75.58% 462B
+2.09%-2.06%+32.28%+37.41% 344B
0.00%+5.36%+27.40%+46.97% 307B
+1.42%+0.26%-0.52%+13.51% 251B
+0.29%+1.63%+56.46%+73.00% 239B
-0.03%+2.13%-17.30%-53.65% 207B
+1.08%+1.59%+33.83%+97.29% 186B
Average +0.65%+0.01%+28.66%+45.81% 369.56B
Weighted average by Cap. +0.34%+0.39%+38.62%+67.81%

Financials

2026 *2027 *
Net sales 1.21B 1.4B 1.13B 1.04B 1.94B 133B 1.95B 13.42B 5.22B 67.86B 5.27B 5.16B 219B 1.25B 1.46B 1.18B 1.08B 2.01B 138B 2.03B 13.93B 5.42B 70.43B 5.48B 5.36B 227B
Net income 137M 160M 129M 118M 220M 15.08B 222M 1.52B 593M 7.71B 599M 586M 24.82B 155M 181M 146M 133M 249M 17.07B 251M 1.72B 672M 8.72B 678M 663M 28.09B
Net Debt 812M 943M 762M 697M 1.3B 89.18B 1.31B 9.01B 3.51B 45.58B 3.54B 3.47B 147B 687M 798M 645M 590M 1.1B 75.47B 1.11B 7.63B 2.97B 38.57B 3B 2.93B 124B
Logo Dermapharm Holding SE
Dermapharm Holding SE is a Germany-based company engaged in manufacturing of patent-free branded pharmaceuticals. The Company operates through two segments: Branded pharmaceuticals and other healthcare products, which includes in-house development, in-house production, and distribution of branded pharmaceuticals and other healthcare products, and Parallel import business, which operates under the axicorp brand. It holds around 950 marketing authorizations for more than 250 active pharmaceutical ingredients, which are marketed as pharmaceuticals, dietary supplements or supplemental balanced diets. The Company offers its products through a number of brands, including Dekristol, Ampho Moronal, Keltican, Tromcardin, among others. It is active primarily in Germany, Switzerland and Austria. Additionally, it operates production facility in Germany. Trommsdorff & GmbH Co KG is a subsidiary of the Company.
Employees
3,619
Date Price Change Volume
03/09/26 €38.95 +1.70% 40,395
02/09/26 €38.30 -1.79% 38,152
01/09/26 €39.00 0.00% 11,839
31/08/26 €39.00 -1.39% 476,211
28/08/26 €39.55 -1.37% 28,808
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
38.95EUR
Average target price
51.00EUR
Spread / Average Target
+30.94%

Quarterly revenue - Rate of surprise